Advertisement

Topics

Nautilus, Inc. Reports Results for the Fourth Quarter and Full Year 2016

16:05 EST 21 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Fourth Quarter Revenue Increased 15% Over Prior Year to $125.8 million Fourth Quarter Operating Income Increased 56% to $19.3 million EPS from continuing operations increased 19% to $0.38 cents Febru...

Other Sources for this Article

Investor Relations Contact:
ICR, LLC
John Mills, 646-277-1254

NEXT ARTICLE

More From BioPortfolio on "Nautilus, Inc. Reports Results for the Fourth Quarter and Full Year 2016"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...